Freedom Holding to Build $2bn Sovereign AI Hub in Kazakhstan with Nvidia Gear
Crowdfund Insider· 2025-11-09 23:12
Core Insights - Freedom Holding Corp has signed an agreement with Kazakhstan's Ministry of Artificial Intelligence and Digital Development to establish a $2 billion "Sovereign AI Hub" in Kazakhstan, aiming to create one of the largest dedicated AI facilities in the region [1][4] - The project will utilize Nvidia's exascale AI infrastructure and is intended to enhance Kazakhstan's local AI capabilities and attract workloads from Central Asia [1][3] Group 1: Project Details - The hub will be located in Kazakhstan and will have access to 100 megawatts of power, classifying it as a hyperscale data center [2] - Freedom will serve as the principal financing and implementation partner for the project, although specific details regarding the timeline, financing breakdown, and procurement have not been disclosed [3] Group 2: Strategic Importance - The initiative aligns with global trends where governments are seeking to maintain "sovereign" AI capabilities to keep data and model training within national borders while leveraging global technology ecosystems [4] - The establishment of the hub is expected to strengthen Kazakhstan's competitiveness, enhance AI expertise, and support long-term growth in digital industries [5]
Tronox Holdings plc 2025 Q3 - Results - Earnings Call Presentation (NYSE:TROX) 2025-11-09
Seeking Alpha· 2025-11-09 23:12
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...
Workiva Inc. 2025 Q3 - Results - Earnings Call Presentation (NYSE:WK) 2025-11-09
Seeking Alpha· 2025-11-09 23:11
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...
Ares Management Corporation 2025 Q3 - Results - Earnings Call Presentation (NYSE:ARES) 2025-11-09
Seeking Alpha· 2025-11-09 23:09
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...
Vanguard VYM Offers Broader Diversification Than NOBL
The Motley Fool· 2025-11-09 23:09
The Vanguard High Dividend Yield ETF (VYM +0.50%) and the ProShares - S&P 500 Dividend Aristocrats ETF (NOBL +1.08%) differ most in cost, breadth, and yield: VYM holds 589 stocks and charges lower fees, while NOBL targets S&P 500 dividend consistency.The Vanguard High Dividend Yield ETF tracks a broader index, holding hundreds of U.S. stocks forecasted to pay above-average dividends. VYM stands out as more affordable, with a 0.06% fee as of Oct. 31, 2025—less than one-fifth of NOBL’s 0.35%—potentially appe ...
Hyatt Hotels Corporation 2025 Q3 - Results - Earnings Call Presentation (NYSE:H) 2025-11-09
Seeking Alpha· 2025-11-09 23:08
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...
Robinhood Markets, Inc. 2025 Q3 - Results - Earnings Call Presentation (NASDAQ:HOOD) 2025-11-09
Seeking Alpha· 2025-11-09 23:07
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...
Vir Biotechnology Announces AASLD The Liver Meeting® Presentation & New England Journal of Medicine Publication of Phase 2 Data Demonstrating Tobevibart & Elebsiran Combination Deliver High Rates of Undetectable HDV RNA with Favorable Safety Profile
Businesswire· 2025-11-09 23:07
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Week 48 endpoint analysis from the Company's Phase 2 SOLSTICE trial for chronic hepatitis delta (CHD) demonstrated that participants receiving a monthly dose of the combination of tobevibart and elebsiran achieved robust and sustained rates of hepatitis delta virus (HDV) RNA target not detected (TND), including those participants with cirrhosis and high baseline HDV RNA. The combination also showed alanin. ...
Regional Management Corp. 2025 Q3 - Results - Earnings Call Presentation (NYSE:RM) 2025-11-09
Seeking Alpha· 2025-11-09 23:07
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...
Pampa Energía S.A. 2025 Q3 - Results - Earnings Call Presentation (NYSE:PAM) 2025-11-09
Seeking Alpha· 2025-11-09 23:05
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...